Effects of the interactions of classical swine fever virus Core protein with proteins of the SUMOylation pathway on virulence in swine

Virology

Volumn 407, Issue 1, 2010, Pages 129-136

  Gladue, D P ^a   Holinka, L G ^a   Fernandez Sainz, I J ^a   Prarat, M V ^a   O'Donell, V ^a,b   Vepkhvadze, N ^a   Lu, Z ^a   Rogers, K ^b   Risatti, G R ^b   Borca, M V ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Attenuation; Classical swine fever virus; Core protein; Pathogenesis; SUMOylation; Vaccines; Virulence

Indexed keywords

COMPLEMENTARY DNA; CORE PROTEIN; PROTEIN UBC9; SUMO 1 PROTEIN; LYSINE; MUTANT PROTEIN; PROTEIN BINDING; UBIQUITIN CONJUGATING ENZYME;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PESTIVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN TARGETING; SUMOYLATION; SWINE; VIROGENESIS; VIRUS SHEDDING; VIRUS TITRATION; VIRUS VIRULENCE; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PATHOLOGY; SEQUENCE ALIGNMENT; VIROLOGY; VIRULENCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; LYSINE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SEQUENCE ALIGNMENT; SUMO-1 PROTEIN; SWINE; UBIQUITIN-CONJUGATING ENZYMES; VIRAL CORE PROTEINS; VIRULENCE;

CLASSICAL SWINE FEVER VIRUS; SUIDAE;

EID: 77956936911     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.07.040     Document Type: Article

References (67)

1. Ahn J.H., Xu Y., Jang W.J., Matunis M.J., Hayward G.S. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J. Virol. 2001, 75:3859-3872.
2. 2+-charged talon resin. Protein Expr. Purif. 2007, 54:289-294.
3. Chang T.H., Kubota T., Matsuoka M., Jones S., Bradfute S.B., Bray M., Ozato K. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 2009, 5:e1000493.
4. Chen C.H., Sheu J.C., Wang J.T., Huang G.T., Yang P.M., Lee H.S., Lee C.Z., Chen D.S. Genotypes of hepatitis C virus in chronic liver disease in Taiwan. J. Med. Virol. 1994, 44:234-236.
5. Chien C.T., Bartel P.L., Sternglanz R., Fields S. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:9578-9582.
6. Chiocca S. Viral control of the SUMO pathway: Gam1, a model system. Biochem. Soc. Trans. 2007, 35:1419-1421.
7. Chiu M.W., Shih H.M., Yang T.H., Yang Y.L. The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). J. Biomed. Sci. 2007, 14:429-444.
8. Desterro J.M., Thomson J., Hay R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 1997, 417:297-300.
9. Edwards S., Moennig V., Wensvoort G. The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses. Vet. Microbiol. 1991, 29:101-108.
10. Eisen-Vandervelde A.L., Waggoner S.N., Yao Z.Q., Cale E.M., Hahn C.S., Hahn Y.S. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J. Biol. Chem. 2004, 279:43479-43486.
11. Fan Z., Yang Q.R., Twu J.S., Sherker A.H. Specific in vitro association between the hepatitis C viral genome and core protein. J. Med. Virol. 1999, 59:131-134.
12. VIRUS TAXONOMY: VIIIth Report of the International Committee on Taxonomy of Viruses 2005, ICTV. C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
13. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature 1989, 340:245-246.
14. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
15. Giannini C., Brechot C. Hepatitis C virus biology. Cell Death Differ. 2003, 10(Suppl 1):S27-S38.
16. Goh P.Y., Tan Y.J., Lim S.P., Lim S.G., Tan Y.H., Hong W.J. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. Virology 2001, 290:224-236.
17. Gong L., Kamitani T., Fujise K., Caskey L.S., Yeh E.T. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 1997, 272:28198-28201.
18. Huang X., Madan A. CAP3: a DNA sequence assembly program. Genome Res. 1999, 9:868-877.
19. Huh Y.H., Kim Y.E., Kim E.T., Park J.J., Song M.J., Zhu H., Hayward G.S., Ahn J.H. Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J. Virol. 2008, 82:10444-10454.
20. Jin D.Y., Wang H.L., Zhou Y., Chun A.C., Kibler K.V., Hou Y.D., Kung H., Jeang K.T. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J. 2000, 19:729-740.
21. Johnson E.S., Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 1997, 272:26799-26802.
22. Kerscher O. SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 2007, 8:550-555.
23. Kittlesen D.J., Chianese-Bullock K.A., Yao Z.Q., Braciale T.J., Hahn Y.S. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 2000, 106:1239-1249.
24. Kunkel M., Lorinczi M., Rijnbrand R., Lemon S.M., Watowich S.J. Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J. Virol. 2001, 75:2119-2129.
25. Lai M.M., Ware C.F. Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr. Top. Microbiol. Immunol. 2000, 242:117-134.
26. Levrero M. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 2006, 25:3834-3847.
27. Liu J.J., Wong M.L., Chang T.J. The recombinant nucleocapsid protein of classical swine fever virus can act as a transcriptional regulator. Virus Res. 1998, 53:75-80.
28. Lo S.Y., Selby M.J., Ou J.H. Interaction between hepatitis C virus core protein and E1 envelope protein. J. Virol. 1996, 70:5177-5182.
29. Mamiya N., Worman H.J. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 1999, 274:15751-15756.
30. Masaki T., Suzuki R., Murakami K., Aizaki H., Ishii K., Murayama A., Date T., Matsuura Y., Miyamura T., Wakita T., Suzuki T. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J. Virol. 2008, 82:7964-7976.
31. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral Hepat. 2000, 7:2-14.
32. Meyers G., Rumenapf T., Thiel H.J. Molecular cloning and nucleotide sequence of the genome of hog cholera virus. Virology 1989, 171:555-567.
33. Meyers G., Saalmuller A., Buttner M. Mutations abrogating the RNase activity in glycoprotein E(rns) of the pestivirus classical swine fever virus lead to virus attenuation. J. Virol. 1999, 73:10224-10235.
34. Mukhopadhyay D., Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 2007, 32:286-295.
35. Murray C.L., Marcotrigiano J., Rice C.M. Bovine viral diarrhea virus core is an intrinsically disordered protein that binds RNA. J. Virol. 2008, 82:1294-1304.
36. Niedenthal R. Ubc9 fusion-directed SUMOylation (UFDS). Biochem. Soc. Trans. 2007, 35:1430-1432.
37. Okuma T., Honda R., Ichikawa G., Tsumagari N., Yasuda H. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 1999, 254:693-698.
38. Otsuka M., Kato N., Lan K., Yoshida H., Kato J., Goto T., Shiratori Y., Omata M. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 2000, 275:34122-34130.
39. Palacios S., Perez L.H., Welsch S., Schleich S., Chmielarska K., Melchior F., Locker J.K. Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association. Mol. Biol. Cell 2005, 16:2822-2835.
40. Ray R.B., Ray R. Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol. Lett. 2001, 202:149-156.
41. Reed L.J., Muench H.A. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27:493-497.
42. Rice C.M. Flaviviridae: the viruses and their replication. Fundamental Virology 1996, 931-959. Lippincott Raven, Philadelphia. Third ed. B.N.F.D.M. Knipe, P. Howley (Eds.).
43. Risatti G.R., Borca M.V., Kutish G.F., Lu Z., Holinka L.G., French R.A., Tulman E.R., Rock D.L. The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine. J. Virol. 2005, 79:3787-3796.
44. Risatti G.R., Holinka L.G., Lu Z., Kutish G.F., Tulman E.R., French R.A., Sur J.H., Rock D.L., Borca M.V. Mutation of E1 glycoprotein of classical swine fever virus affects viral virulence in swine. Virology 2005, 343:116-127.
45. Risatti G.R., Holinka L.G., Carrillo C., Kutish G.F., Lu Z., Tulman E.R., Sainz I.F., Borca M.V. Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus. Virology 2006, 355:94-101.
46. Risatti G.R., Holinka L.G., Fernandez Sainz I., Carrillo C., Lu Z., Borca M.V. N-linked glycosylation status of classical swine fever virus strain Brescia E2 glycoprotein influences virulence in swine. J. Virol. 2007, 81:924-933.
47. Rodriguez M.S., Dargemont C., Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 2001, 276:12654-12659.
48. Sadanari H., Yamada R., Ohnishi K., Matsubara K., Tanaka J. SUMO-1 modification of the major immediate-early (IE) 1 and 2 proteins of human cytomegalovirus is regulated by different mechanisms and modulates the intracellular localization of the IE1, but not IE2, protein. Arch. Virol. 2005, 150:1763-1782.
49. Sampson D.A., Wang M., Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 2001, 276:21664-21669.
50. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:5463-5467.
51. Sarge K.D., Park-Sarge O.K. Sumoylation and human disease pathogenesis. Trends Biochem. Sci. 2009, 34:200-205.
52. Seeler J.S., Dejean A. Nuclear and unclear functions of SUMO. Nat. Rev. Mol. Cell Biol. 2003, 4:690-699.
53. Shimoike T., Mimori S., Tani H., Matsuura Y., Miyamura T. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J. Virol. 1999, 73:9718-9725.
54. Shirai C., Mizuta K. SUMO mediates interaction of Ebp2p, the yeast homolog of Epstein-Barr virus nuclear antigen 1-binding protein 2, with a RING finger protein Ris1p. Biosci. Biotechnol. Biochem. 2008, 72:1881-1886.
55. Tanaka Y., Shimoike T., Ishii K., Suzuki R., Suzuki T., Ushijima H., Matsuura Y., Miyamura T. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome. Virology 2000, 270:229-236.
56. Tellinghuisen T.L., Rice C.M. Interaction between hepatitis C virus proteins and host cell factors. Curr. Opin. Microbiol. 2002, 5:419-427.
57. Terpstra C., Woortmeyer R., Barteling S.J. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch. Tierarztl. Wochenschr. 1990, 97:77-79.
58. rns RNase prevents homodimer formation and leads to attenuation of classical swine fever virus. J. Virol. 2009, 83:4823-4834.
59. Tomoiu A., Gravel A., Tanguay R.M., Flamand L. Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. J. Virol. 2006, 80:10218-10228.
60. Van Gennip H.G., Vlot A.C., Hulst M.M., De Smit A.J., Moormann R.J. Determinants of virulence of classical swine fever virus strain Brescia. J. Virol. 2004, 78:8812-8823.
61. Yao Z.Q., Nguyen D.T., Hiotellis A.I., Hahn Y.S. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 2001, 167:5264-5272.
62. Yao Z.Q., King E., Prayther D., Yin D., Moorman J. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunol. 2007, 20:276-287.
63. Yoshida T., Hanada T., Tokuhisa T., Kosai K., Sata M., Kohara M., Yoshimura A. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J. Exp. Med. 2002, 196:641-653.
64. You L.R., Chen C.M., Yeh T.S., Tsai T.Y., Mai R.T., Lin C.H., Lee Y.H. Hepatitis C virus core protein interacts with cellular putative RNA helicase. J. Virol. 1999, 73:2841-2853.
65. Yueh A., Leung J., Bhattacharyya S., Perrone L.A., de los Santos K., Pu S.Y., Goff S.P. Interaction of Moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection. J. Virol. 2006, 80:342-352.
66. Zhong N., Radu G., Ju W., Brown W.T. Novel progerin-interactive partner proteins hnRNP E1, EGF, Mel 18, and UBC9 interact with lamin A/C. Biochem. Biophys. Res. Commun. 2005, 338:855-861.
67. Zsak L., Lu Z., Kutish G.F., Neilan J.G., Rock D.L. An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene. J. Virol. 1996, 70:8865-8871.